Search
for

    Sort by

    Research 30 of 1000+

    1. Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege European Journal of Dermatology · 2014 · 10 citations
    2. Bullous Lesions at Polyethylene Glycol Interferon-alpha-2a Inoculation Site in a Hepatitis C Virus-infected Subject Acta Dermato Venereologica · 2007 · 2 citations
    3. Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report Annals of Hepatology · 2014 · 3 citations
    4. Interferon in the treatment of cutaneous T-cell lymphoma Dermatologic Therapy · 2003 · 107 citations
    5. Medical therapy for frontal fibrosing alopecia: A review and clinical approach Journal of The American Academy of Dermatology · 2019 · 37 citations
    6. INTERFERONS IN DERMATOLOGY Dermatologic Clinics · 1998 · 22 citations
    7. Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases International Journal of Molecular Sciences · 2024 · 1 citations
    8. Medical Treatment of Hepatocellular Carcinoma: Any Progress? Tumori Journal · 1994 · 19 citations
    9. Hair, Cutaneous Homeostasis and Stem Cell Functions Journal of Investigative Dermatology · 2014
    10. Telogen Effluvium due to Recombinant Interferon α-2b Dermatology · 2009 · 45 citations
    11. Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection European Journal of Gastroenterology & Hepatology · 2007 · 41 citations
    12. Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy Hepatitis Monthly · 2015 · 2 citations
    13. Cutaneous drug reactions Elsevier eBooks · 2010 · 1 citations
    14. Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review Hepatology Research · 2012 · 9 citations
    15. Drug-Induced Hair Loss and Hair Growth Drug Safety · 1994 · 147 citations
    16. Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis Clinical Cosmetic and Investigational Dermatology · 2025
    17. Hair Changes due to Drugs Elsevier eBooks · 2018
    18. Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review) Oncology Reports · 2012 · 46 citations
    19. ALOPESİ AREATA TEDAVİSİNDE POTANSİYEL BAZI TIBBİ BİTKİ TÜRLERİNİN İNCELENMESİ Ankara Universitesi Eczacilik Fakultesi Dergisi · 2025
    20. An overview of management of drug-induced hair and nail disorders Clinical practice · 2014 · 7 citations
    21. Trichodysplasia of immunosuppression treated with oral valganciclovir Journal of the American Academy of Dermatology · 2008 · 41 citations
    22. The hair follicle enigma Experimental Dermatology · 2017 · 25 citations
    23. First Report on Microbial-Derived Polydeoxyribonucleotide: A Sustainable and Enhanced Alternative to Salmon-Based Polydeoxyribonucleotide Current Issues in Molecular Biology · 2025 · 7 citations
    24. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020 International Journal of Molecular Sciences · 2020 · 848 citations
    25. Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System 2019 · 142 citations
    26. Leveraging nature’s nanocarriers: Translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications Science Advances · 2025 · 49 citations
    27. Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies Pharmaceuticals · 2023 · 43 citations
    28. Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies Preprints.org · 2023 · 18 citations
    29. Emerging Role of Dermal White Adipose Tissue in Modulating Hair Follicle Development During Aging Frontiers in Cell and Developmental Biology · 2021 · 5 citations
    30. The therapeutic efficacy of mesenchymal stem cells and their extracellular vesicles in the treatment of diverse skin diseases Frontiers in Immunology · 2025 · 4 citations